Sorrento Therapeutics, Inc. (SRNE)
0.0005
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Sorrento Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | -1.012 |
| March 31, 2023 | -1.351 |
| December 31, 2022 | -7.230 |
| September 30, 2022 | 1.276 |
| June 30, 2022 | 1.550 |
| March 31, 2022 | 1.099 |
| December 31, 2021 | 3.017 |
| September 30, 2021 | 1.540 |
| June 30, 2021 | 0.8849 |
| March 31, 2021 | 0.6687 |
| December 31, 2020 | 1.026 |
| September 30, 2020 | 1.085 |
| June 30, 2020 | 1.609 |
| March 31, 2020 | 2.524 |
| December 31, 2019 | 3.700 |
| September 30, 2019 | 6.899 |
| June 30, 2019 | 3.715 |
| March 31, 2019 | 2.187 |
| December 31, 2018 | 1.114 |
| September 30, 2018 | 0.7842 |
| June 30, 2018 | 0.0696 |
| March 31, 2018 | 0.0302 |
| December 31, 2017 | 0.0261 |
| September 30, 2017 | 0.284 |
| June 30, 2017 | 0.2872 |
| Date | Value |
|---|---|
| March 31, 2017 | 0.4514 |
| December 31, 2016 | 0.5912 |
| September 30, 2016 | 0.0458 |
| June 30, 2016 | 0.037 |
| March 31, 2016 | 0.085 |
| December 31, 2015 | 0.0636 |
| September 30, 2015 | 0.0709 |
| June 30, 2015 | 0.1258 |
| March 31, 2015 | 0.1219 |
| December 31, 2014 | 0.1117 |
| September 30, 2014 | 0.1705 |
| June 30, 2014 | 0.1544 |
| March 31, 2014 | 0.2029 |
| December 31, 2013 | 0.0719 |
| September 30, 2013 | 0.155 |
| June 30, 2013 | 0.1434 |
| March 31, 2013 | 0.0848 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |